Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Short-Term Outcomes in Patients With Coexistence of COVID-19 Infection and Vitamin D Deficiency: A Large Cohort Study

Chan et al., Cureus, doi:10.7759/cureus.71952
Oct 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 6% Improvement Relative Risk Progression, death, hospit.. 5% Progression, critical care 22% Hospitalization 1% Vitamin D for COVID-19  Chan et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 68,814 patients in multiple countries (Jan 2022 - Sep 2024) Lower progression with higher vitamin D levels (p=0.02) c19early.org Chan et al., Cureus, October 2024 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
PSM retrospective 68,814 COVID-19 patients showing vitamin D deficiency associated with significantly increased risk of requiring critical care services, and non-significant higher all-cause mortality. Mortality for COVID-19 was less likely during the latter pandemic period used in this study, and the baseline risk of hospitalization and mortality may attenuate the effect seen. Authors hypothesize that vitamin D may reduce disease severity by modulating the immune response and mitigating the cytokine storm associated with severe COVID-19.
This is the 207th of 211 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 248,027,826 vigintillion).
risk of death, 5.7% lower, HR 0.94, p = 0.42, high D levels (≥20ng/mL) 365 of 34,407 (1.1%), low D levels (<20ng/mL) 382 of 34,407 (1.1%), NNT 2024, inverted to make HR<1 favor high D levels (≥20ng/mL), Cox proportional hazards.
risk of progression, 4.8% lower, HR 0.95, p = 0.02, high D levels (≥20ng/mL) 4,181 of 34,407 (12.2%), low D levels (<20ng/mL) 4,345 of 34,407 (12.6%), NNT 210, inverted to make HR<1 favor high D levels (≥20ng/mL), death, hospitalization, critical care, Cox proportional hazards.
risk of progression, 21.9% lower, HR 0.78, p < 0.001, high D levels (≥20ng/mL) 702 of 34,407 (2.0%), low D levels (<20ng/mL) 885 of 34,407 (2.6%), NNT 188, inverted to make HR<1 favor high D levels (≥20ng/mL), critical care, Cox proportional hazards.
risk of hospitalization, 1.0% lower, HR 0.99, p = 0.80, high D levels (≥20ng/mL) 3,812 of 34,407 (11.1%), low D levels (<20ng/mL) 3,803 of 34,407 (11.1%), inverted to make HR<1 favor high D levels (≥20ng/mL), Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Chan et al., 20 Oct 2024, retrospective, multiple countries, peer-reviewed, 3 authors, study period January 2022 - September 2024. Contact: andy10271@gmail.com.
This PaperVitamin DAll
Short-Term Outcomes in Patients With Coexistence of COVID-19 Infection and Vitamin D Deficiency: A Large Cohort Study
Yi-Ju Chan, Chia-Chen Chen, Jheng-Yan Wu
Cureus, doi:10.7759/cureus.71952
Introduction: Vitamin D deficiency (VDD) is prevalent worldwide and may influence the severity of infectious diseases, including COVID-19. This study aimed to evaluate the association between VDD and 30day clinical outcomes in patients with COVID-19. Methods: We conducted a retrospective cohort study using data from the TriNetX database, which includes de-identified electronic health records of approximately 155 million patients from 131 healthcare organizations globally. Adult patients (aged ≥18 years) with their first documented COVID-19 infection between January 2022 and September 2024 were included. Patients were categorized based on their vitamin D status within three months prior to COVID-19 diagnosis: those with documented VDD (VDD group) and those without (controls). Outcomes assessed were all-cause mortality, all-cause hospitalization, the requirement for critical care services, and a composite outcome of these events at 30-day followup. Propensity score matching (PSM) was utilized to balance covariates such as age, sex, race, and comorbidities between the groups. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox regression analysis. Results: After PSM, the study included 68,814 patients, with 34,407 in both the VDD and control groups. VDD was associated with a slight but statistically significant increase in the hazard of experiencing the composite outcome (HR 1.05, 95% CI 1.01-1.10, P=0.02). There was no significant difference in all-cause mortality (HR 1.06, 95% CI 0.92-1.22, P=0.42) or all-cause hospitalization (HR 1.01, 95% CI 0.96-1.05, P=0.80) between the groups. However, patients with VDD had a significantly higher hazard of requiring critical care services compared to controls (HR 1.28, 95% CI 1.16-1.41, P<0.01). Conclusion: Vitamin D deficiency is associated with an increased risk of requiring critical care services among COVID-19 patients, suggesting that VDD may contribute to greater disease severity. These findings underscore the potential importance of assessing and managing vitamin D deficiency in patients with COVID-19 to improve clinical outcomes.
Author Contributions All authors have reviewed the final version to be published and agreed to be accountable for all aspects of the work. Concept and design: Jheng-Yan Wu, Yi-Ju Chan, Chia-Chen Chen Acquisition, analysis, or interpretation of data: Jheng-Yan Wu, Yi-Ju Chan, Chia-Chen Chen Critical review of the manuscript for important intellectual content: Jheng-Yan Wu Drafting of the manuscript: Yi-Ju Chan, Chia-Chen Chen Disclosures Human subjects: Consent was obtained or waived by all participants in this study. Institutional Review Board of the Chi Mei Medical Center issued approval 11302-E01. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
References
Amrein, Papinutti, Mathew, Vila, Parekh, Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa, Endocr Connect, doi:10.1530/EC-18-0184
Ashique, Gupta, Gupta, Vitamin D-A prominent immunomodulator to prevent COVID-19 infection, Int J Rheum Dis, doi:10.1111/1756-185X.14477
Barrett, Youssef, Shah, Vitamin D status and mortality from SARS CoV-2: a prospective study of unvaccinated Caucasian adults, Nutrients, doi:10.3390/nu14163252
Chen, Ho, Liu, Wu, Huang et al., Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2442686 patients, J Med Virol, doi:10.1002/jmv.28745
Dhawan, Priyanka, Op, Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19, Hum Vaccin Immunother, doi:10.1080/21645515.2022.2025734
Di Filippo, Uygur, Locatelli, Nannipieri, Frara et al., Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization, Endocrine, doi:10.1007/s12020-023-03331-9
Getachew, Tizabi, Vitamin D and COVID-19: role of ACE2, age, gender, and ethnicity, et al. Cureus, doi:10.1002/jmv.27075
Kiyumi, Kalra, Davies, Kalhan, The impact of vitamin D deficiency on the severity of symptoms and mortality rate among adult patients with COVID-19: a systematic review and meta-analysis, Indian J Endocrinol Metab, doi:10.4103/ijem.ijem_115_21
Merzon, Tworowski, Gorohovski, Vinker, Cohen et al., Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study, FEBS J, doi:10.1111/febs.15495
Nielsen, Junker, Boelt, Vitamin D status and severity of COVID-19, Sci Rep, doi:10.1038/s41598-022-21513-9
Raju, Luthra, Shahbaz, Role of vitamin D deficiency in increased susceptibility to respiratory infections among children: a systematic review, Cureus, doi:10.7759/cureus.29205
Wu, Chen, Liu, Clinical effectiveness of nirmatrelvir plus ritonavir on the short-and longterm outcome in high-risk children with COVID-19, J Med Virol, doi:10.1002/jmv.29662
Wu, Liu, Hsu, Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection, Eur J Nutr, doi:10.1007/s00394-023-03298-3
Wu, Liu, Hung, Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: a six-month retrospective cohort analysis of 30 892 patients, J Med Virol, doi:10.1002/jmv.29246
Wu, Liu, Liu, Association between nirmatrelvir plus ritonavir and the outcomes of nonhospitalized obese patients with COVID-19, Int J Antimicrob Agents, doi:10.1016/j.ijantimicag.2023.106984
Wu, Liu, Liu, Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19, J Med Virol, doi:10.1002/jmv.28866
{ 'indexed': { 'date-parts': [[2024, 10, 21]], 'date-time': '2024-10-21T00:40:19Z', 'timestamp': 1729471219990, 'version': '3.27.0'}, 'reference-count': 16, 'publisher': 'Springer Science and Business Media LLC', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2024, 10, 20]]}, 'DOI': '10.7759/cureus.71952', 'type': 'journal-article', 'created': { 'date-parts': [[2024, 10, 21]], 'date-time': '2024-10-21T00:14:20Z', 'timestamp': 1729469660000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Short-Term Outcomes in Patients With Coexistence of COVID-19 Infection and Vitamin D Deficiency: ' 'A Large Cohort Study', 'prefix': '10.7759', 'author': [ {'given': 'Yi-Ju', 'family': 'Chan', 'sequence': 'first', 'affiliation': []}, {'given': 'Chia-Chen', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jheng-Yan', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'reference': [ { 'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.28745', 'article-title': 'Long-term risk of herpes zoster following COVID-19: a retrospective ' 'cohort study of 2442686 patients', 'volume': '95', 'author': 'Chen YC', 'year': '2023', 'unstructured': 'Chen YC, Ho CH, Liu TH, Wu JY, Huang PY, Tsai YW, Lai CC. Long-term risk ' 'of herpes zoster following COVID-19: a retrospective cohort study of ' '2442686 patients. J Med Virol. 2023, 95:e28745. 10.1002/jmv.28745', 'journal-title': 'J Med Virol'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.29246', 'article-title': 'Nutritional deficiency anemia and post-acute sequelae in patients with ' 'severe acute respiratory syndrome coronavirus 2 infection: a six-month ' 'retrospective cohort analysis of 30\u2009892 patients', 'volume': '95', 'author': 'Wu JY', 'year': '2023', 'unstructured': 'Wu JY, Liu MY, Hung KC, et al.. Nutritional deficiency anemia and ' 'post-acute sequelae in patients with severe acute respiratory syndrome ' 'coronavirus 2 infection: a six-month retrospective cohort analysis of ' '30\u2009892 patients. J Med Virol. 2023, 95:e29246. 10.1002/jmv.29246', 'journal-title': 'J Med Virol'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00394-023-03298-3', 'article-title': 'Association between vitamin D deficiency and post-acute outcomes of ' 'SARS-CoV-2 infection', 'volume': '63', 'author': 'Wu JY', 'year': '2024', 'unstructured': 'Wu JY, Liu MY, Hsu WH, et al.. Association between vitamin D deficiency ' 'and post-acute outcomes of SARS-CoV-2 infection. Eur J Nutr. 2024, ' '63:613-22. 10.1007/s00394-023-03298-3', 'journal-title': 'Eur J Nutr'}, { 'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.7759/cureus.29205', 'article-title': 'Role of vitamin D deficiency in increased susceptibility to respiratory ' 'infections among children: a systematic review', 'volume': '14', 'author': 'Raju A', 'year': '2022', 'unstructured': 'Raju A, Luthra G, Shahbaz M, et al.. Role of vitamin D deficiency in ' 'increased susceptibility to respiratory infections among children: a ' 'systematic review. Cureus. 2022, 14:e29205. 10.7759/cureus.29205', 'journal-title': 'Cureus'}, { 'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu14163252', 'article-title': 'Vitamin D status and mortality from SARS CoV-2: a prospective study of ' 'unvaccinated Caucasian adults', 'volume': '14', 'author': 'Barrett R', 'year': '2022', 'unstructured': 'Barrett R, Youssef M, Shah I, et al.. Vitamin D status and mortality ' 'from SARS CoV-2: a prospective study of unvaccinated Caucasian adults. ' 'Nutrients. 2022, 14:10.3390/nu14163252', 'journal-title': 'Nutrients'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.29662', 'article-title': 'Clinical effectiveness of nirmatrelvir plus ritonavir on the short- and ' 'long-term outcome in high-risk children with COVID-19', 'volume': '96', 'author': 'Wu JY', 'year': '2024', 'unstructured': 'Wu JY, Chen CC, Liu MY, et al.. Clinical effectiveness of nirmatrelvir ' 'plus ritonavir on the short- and long-term outcome in high-risk children ' 'with COVID-19. J Med Virol. 2024, 96:e29662. 10.1002/jmv.29662', 'journal-title': 'J Med Virol'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.28866', 'article-title': 'Clinical efficacy of nirmatrelvir and ritonavir combination for ' 'treating diabetic patients with COVID-19', 'volume': '95', 'author': 'Wu JY', 'year': '2023', 'unstructured': 'Wu JY, Liu MY, Liu TH, et al.. Clinical efficacy of nirmatrelvir and ' 'ritonavir combination for treating diabetic patients with COVID-19. J ' 'Med Virol. 2023, 95:e28866. 10.1002/jmv.28866', 'journal-title': 'J Med Virol'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1530/EC-18-0184', 'article-title': 'Vitamin D and critical illness: what endocrinology can learn from ' 'intensive care and vice versa', 'volume': '7', 'author': 'Amrein K', 'year': '2018', 'unstructured': 'Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. Vitamin D and ' 'critical illness: what endocrinology can learn from intensive care and ' 'vice versa. Endocr Connect. 2018, 7:R304-15. 10.1530/EC-18-0184', 'journal-title': 'Endocr Connect'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijantimicag.2023.106984', 'article-title': 'Association between nirmatrelvir plus ritonavir and the outcomes of ' 'non-hospitalized obese patients with COVID-19', 'volume': '62', 'author': 'Wu JY', 'year': '2023', 'unstructured': 'Wu JY, Liu MY, Liu TH, et al.. Association between nirmatrelvir plus ' 'ritonavir and the outcomes of non-hospitalized obese patients with ' 'COVID-19. Int J Antimicrob Agents. 2023, 62:106984. ' '10.1016/j.ijantimicag.2023.106984', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41598-022-21513-9', 'article-title': 'Vitamin D status and severity of COVID-19', 'volume': '12', 'author': 'Nielsen NM', 'year': '2022', 'unstructured': 'Nielsen NM, Junker TG, Boelt SG, et al.. Vitamin D status and severity ' 'of COVID-19. Sci Rep. 2022, 12:19823. 10.1038/s41598-022-21513-9', 'journal-title': 'Sci Rep'}, { 'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s12020-023-03331-9', 'article-title': 'Low vitamin D levels predict outcomes of COVID-19 in patients with both ' 'severe and non-severe disease at hospitalization', 'volume': '80', 'author': 'di Filippo L', 'year': '2023', 'unstructured': 'di Filippo L, Uygur M, Locatelli M, Nannipieri F, Frara S, Giustina A. ' 'Low vitamin D levels predict outcomes of COVID-19 in patients with both ' 'severe and non-severe disease at hospitalization. Endocrine. 2023, ' '80:669-83. 10.1007/s12020-023-03331-9', 'journal-title': 'Endocrine'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/febs.15495', 'article-title': 'Low plasma 25(OH) vitamin D level is associated with increased risk of ' 'COVID-19 infection: an Israeli population-based study', 'volume': '287', 'author': 'Merzon E', 'year': '2020', 'unstructured': 'Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, ' 'Frenkel-Morgenstern M. Low plasma 25(OH) vitamin D level is associated ' 'with increased risk of COVID-19 infection: an Israeli population-based ' 'study. FEBS J. 2020, 287:3693-702. 10.1111/febs.15495', 'journal-title': 'FEBS J'}, { 'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.4103/ijem.ijem_115_21', 'article-title': 'The impact of vitamin D deficiency on the severity of symptoms and ' 'mortality rate among adult patients with COVID-19: a systematic review ' 'and meta-analysis', 'volume': '25', 'author': 'Al Kiyumi MH', 'year': '2021', 'unstructured': 'Al Kiyumi MH, Kalra S, Davies JS, Kalhan A. The impact of vitamin D ' 'deficiency on the severity of symptoms and mortality rate among adult ' 'patients with COVID-19: a systematic review and meta-analysis. Indian J ' 'Endocrinol Metab. 2021, 25:261-82. 10.4103/ijem.ijem_115_21', 'journal-title': 'Indian J Endocrinol Metab'}, { 'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/1756-185X.14477', 'article-title': 'Vitamin D-A prominent immunomodulator to prevent COVID-19 infection', 'volume': '26', 'author': 'Ashique S', 'year': '2023', 'unstructured': 'Ashique S, Gupta K, Gupta G, et al.. Vitamin D-A prominent ' 'immunomodulator to prevent COVID-19 infection. Int J Rheum Dis. 2023, ' '26:13-30. 10.1111/1756-185X.14477', 'journal-title': 'Int J Rheum Dis'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/21645515.2022.2025734', 'article-title': 'Immunomodulatory and therapeutic implications of vitamin D in the ' 'management of COVID-19', 'volume': '18', 'author': 'Dhawan M', 'year': '2022', 'unstructured': 'Dhawan M, Priyanka, Choudhary OP. Immunomodulatory and therapeutic ' 'implications of vitamin D in the management of COVID-19. Hum Vaccin ' 'Immunother. 2022, 18:2025734. 10.1080/21645515.2022.2025734', 'journal-title': 'Hum Vaccin Immunother'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.27075', 'article-title': 'Vitamin D and COVID-19: role of ACE2, age, gender, and ethnicity', 'volume': '93', 'author': 'Getachew B', 'year': '2021', 'unstructured': 'Getachew B, Tizabi Y. Vitamin D and COVID-19: role of ACE2, age, gender, ' 'and ethnicity. J Med Virol. 2021, 93:5285-94. 10.1002/jmv.27075', 'journal-title': 'J Med Virol'}], 'container-title': 'Cureus', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.cureus.com/articles/310740-short-term-outcomes-in-patients-with-coexistence-of-covid-19-infection-and-vitamin-d-deficiency-a-large-cohort-study', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 10, 21]], 'date-time': '2024-10-21T00:14:21Z', 'timestamp': 1729469661000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/310740-short-term-outcomes-in-patients-with-coexistence-of-covid-19-infection-and-vitamin-d-deficiency-a-large-cohort-study'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 10, 20]]}, 'references-count': 16, 'URL': 'http://dx.doi.org/10.7759/cureus.71952', 'relation': {}, 'ISSN': ['2168-8184'], 'subject': [], 'published': {'date-parts': [[2024, 10, 20]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit